SweetValueLab
Write for us

Insulet Corp. — Financial Statements & Ratios

PODD
NASDAQHealthcareMedical - DevicesCIK 0001145197insulet.comAbout PODD
Last close · Oct 16, 2026141.10+2.33 (+1.68%)
Market cap$9.8B

Key indicators

Revenue3.1BTTM+29.4% on a year earlier+25.1% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
563.8M 738.2M+30.9%904.4M+22.5%1.1B+21.5%1.1B−3.9%1.7B+60.8%2.1B+22.1%2.7B+30.7%3.1B+29.4%3.3B 3.7B 4.3B
— 30.9% 22.5% 21.5% -3.9% 60.8% 22.1% 30.7% 29.4% 21.5% 13.8% 13.7%
$0.05 $0.19+280.0%$0.10−47.4%$0.24+140.0%$0.07−70.8%$2.94+4100.0%$5.78+96.6%$3.48−39.8%$5.33+63.5%$6.50 $7.70 $9.32
Profitability
65.7% 65.1%−0.6 pt64.4%−0.7 pt68.4%+4.1 pt76.3%+7.9 pt68.3%−8.0 pt69.8%+1.4 pt71.6%+1.8 pt71.1%+0.3 pt· · ·
4.9% 6.8%+1.9 pt5.7%−1.1 pt11.5%+5.8 pt3.6%−7.9 pt13.0%+9.4 pt14.9%+1.9 pt17.5%+2.6 pt16.9%−0.4 pt· · ·
0.6% 1.6%+1.0 pt0.8%−0.8 pt1.5%+0.8 pt0.4%−1.1 pt12.2%+11.7 pt20.2%+8.0 pt9.1%−11.1 pt12.3%+2.3 pt· · ·
1.6% 15.3%+13.7 pt1.1%−14.2 pt3.0%+1.9 pt1.0%−2.1 pt28.2%+27.2 pt34.5%+6.4 pt16.3%−18.2 pt— · · ·
Cash
-126.5M -65.3M+48.4%-45.0M+31.1%-180.0M−300.0%-3.9M+97.8%70.1M+1897.4%305.4M+335.7%377.7M+23.7%293.7M−25.7%· · ·
-22.4% -8.8%+13.6 pt-5.0%+3.9 pt-16.4%−11.4 pt-0.4%+16.0 pt4.1%+4.5 pt14.7%+10.6 pt13.9%−0.8 pt9.6%−7.1 pt· · ·
Balance sheet
2.79x 11.70x+8.91x1.75x−9.94x2.29x+0.53x2.94x+0.65x1.93x−1.01x1.14x−0.79x0.63x−0.51x0.67x−0.29x· · ·
61.01M 62.30M+2.1%65.95M+5.8%68.58M+4.0%69.91M+1.9%73.63M+5.3%73.89M+0.3%71.89M−2.7%69.40M−1.8%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.